New CRO partner: Nexus BioQuest

We're happy to announce a partnership with Nexus BioQuest, a preclinical contract research organization specializing in complex immunological assays and translationally relevant in vitro models for drug discovery. 

This partnership connects Mabtech's ELISpot and FluoroSpot assays with Nexus BioQuest's advanced human multicellular models, including the tonsil re-aggregate model and 3D tumor/TME models, which replicate disease-relevant conditions and in vivo cellular interactions.

Together, Mabtech and Nexus BioQuest aim to give immuno-oncology, autoimmunity, inflammation, and neuroinflammation researchers a smoother route from target validation to candidate differentiation against current standards of care, with cytokine and immune cell readouts built on validated, high-sensitivity methods at every stage.

More on Nexus and our other CRO partners.